Purpose Current Brain Trauma Foundation guidelines recommend avoiding hypoxemia after severe pediatric traumatic brain injury (TBI). Yet, recent studies on optimum admission oxygenation and ventilation parameters associated with discharge survival in pediatric TBI are lacking. Materials and methods After IRB approval, a retrospective study involving pediatric patients ages ≤14 years with severe TBI (head Abbreviated Injury Scale (AIS) score of ≥3, Glasgow Coma Scale score of ≤8 on admission) admitted to Harborview Medical Center (level 1 pediatric trauma center), Seattle, WA, during 2003 to 2007 was performed. Admission demographics, clinical data, and laboratory characteristics were abstracted. Hypoxemia was defined as PaO 2 <60 mmHg, hypocarbia was defined as PaCO 2 ≤35 mmHg, and hypercarbia was defined as PaCO 2 ≥46 mmHg. Results One hundred ninety-four patients met inclusion criteria of which 162 (83.5 %) patients survived. Admission hypoxemia occurred in nine (5.6 %) patients who survived and eight (25 %) patients who died (p<0.001). Children with admission PaCO 2 between 36 and 45 mmHg had greater discharge survival compared with those with both admission hypocarbia (PaCO 2 ≤35 mmHg) and hypercarbia (PaCO 2 ≥46 mmHg). Admission PaO 2 301-500 mmHg (adjusted odds ratio (AOR), 8.02 (95 % confidence interval (CI), 1.73-37.10); p00.008) and admission PaCO 2 036-45 mmHg (AOR, 5.47 (95 % CI,); p00.02) were independently associated with discharge survival. Conclusions Discharge survival after severe pediatric TBI was associated with admission PaO 2 301-500 mmHg and PaCO 2 036-45 mmHg. Admission hypocarbia and hypercarbia were each associated with increased discharge mortality.
Introduction
Traumatic Brain Injury (TBI) is the most common cause of injury related pediatric death and disability [1, 2] . Poor outcome after severe pediatric TBI [3] may be associated with second physiological insults such as hypoxemia [4] [5] [6] , hypercarbia [5, 6] , and hypotension [5] [6] [7] [8] . Current Brain Trauma Foundation guidelines recommend prevention and early correction of hypoxemia (PaO 2 <60 mmHg) and avoidance of hypocarbia (PaCO 2 <35 mmHg) after severe pediatric TBI [9] . However, these recommendations are based primarily on scant older data or on data from the pediatric intensive care unit and not from earlier times after injury (emergency department (ED)) after TBI. Moreover, while avoidance of hypoxemia and hypercarbia is recommended, optimal PaO 2 and PaCO 2 levels associated with improved outcomes after pediatric TBI remain largely unknown.
In one retrospective study of children with severe TBI, Michaud et al. reported that pediatric patients with ED admission PaO 2 levels over 350 mmHg had good discharge outcomes than those with PaO 2 levels between 105 and 350 mmHg and that there was no difference in discharge survival or disability between children with ED PaCO 2 < 35 mmHg vs. PaCO 2 ≥35 mmHg [5] . In the other study that examined admission ventilation and outcomes in severe pediatric TBI, hypercarbia which was defined as PaCO 2 > 35 mmHg was found to be associated with poor discharge survival [6] . However, both studies grouped all levels of PaCO 2 greater than 35 mmHg into one category, thereby lumping normocarbia and hypercarbia. Thus, with the exception of PaCO 2 studies in the PICU showing low cerebral blood flow (CBF) with hypocarbia [10] , the effect of admission ventilation parameters on outcomes remain understudied. To add to our understanding of the relationship between oxygenation and ventilation parameters after severe pediatric TBI and outcome, we aimed to determine the relationship between admission PaO 2 and PaCO 2 levels and discharge survival.
Materials and methods

Study design
After Institutional Review Board approval, a retrospective study involving pediatric patients admitted to Harborview Medical Center (level 1 pediatric trauma center), Seattle, WA, during 2003 to 2007 was performed.
Study population
Eligibility criteria included patients aged ≤14 years, with severe TBI defined as Glasgow Coma Scale (GCS) score of ≤8 on admission to the ED, head Abbreviated Injury Scale (AIS) score of ≥3, and TBI ICD codes (800-801.9, 803-804.9, 850-854.1, or 959.01).
General approach to severe TBI management During the study period, patients were resuscitated according to institutional practice, which is consistent with the 2003 Brain Trauma Foundation Guidelines [9] . Relevant to this study, general approach to severe pediatric TBI management includes sedation, analgesia, mechanical ventilation, intracranial pressure (ICP) monitoring via camino or ventriculostomy, care aimed at maintaining ICP at <20 mmHg, CPP at >40 mmHg, PaCO 2 at 35-40 mmHg, SaO 2 at >90 %, and maintaining core body temperature between 35 and 37.5°C with antipyretics, cooling/warming blankets, or intravascular cooling devices if needed. Hyperventilation was used only as a temporizing measure in cases of impending brain herniation or refractory intracranial hypertension. During the study period, utilization of the measures of cerebral oxygenation, including brain tissue oxygenation and jugular venous oximetry was patient specific and were at the discretion of the treating physician.
Data sources
Harborview Medical Center Trauma Registry, electronic medical records, and laboratory information system records were used to compile the final data set. Trauma registry records were used to abstract demographics and select clinical characteristics including outcomes.
Data abstracted
The following patient level characteristics were abstracted: demographic data (age and gender), admission GCS score, Head AIS score, Injury Severity Score (ISS), presence or absence of admission hypotension, presence or absence of chest injuries (ICD codes 860.0-860. 5, 861.1-861.3, or 862.0-862.3), discharge GCS score, discharge mortality, and discharge disposition. Laboratory data extracted included PaO 2 , PaCO 2, FiO 2, PaO 2 / FiO 2 , blood glucose, and hematocrit recorded at the time of ED admission.
Outcomes
The main outcome measure was all-cause discharge survival.
Definitions/categories
Hypotension was defined as systolic blood pressure of less than 5th percentile (age×2+70) [9] . Hypoxemia as was defined as PaO 2 <60 mmHg. We also categorized admission PaO 2 into four groups [5] : group 1, PaO 2 ≤100 mmHg; group 2, PaO 2 101-300 mmHg; group 3, PaO 2 301-500 mmHg; and group 4, PaO 2 ≥500 mmHg. Hypocarbia was defined as PaCO 2 ≤ 35 mmHg, normocarbia was defined as PaCO 2 036-45 mmHg, and hypercarbia was defined as PaCO 2 ≥46 mmHg.
Statistical analysis
Statistical analysis was performed using IBM SPSS 19 software. Demographic and clinical data (admission GCS, head AIS, ISS, admission PaO 2 , PaCO 2, FiO 2, blood glucose, and hematocrit) were evaluated for normality and then analyzed with nonparametric Mann-Whitney rank sum test and differences in these parameters were examined for discharge survival and death (Table 1) . Nominal data (gender, presence or absence of chest trauma, and presence or absence of admission hypotension) were analyzed using Chi-square test and are described as n (in percent). The distribution of admission PaCO 2 and PaO 2 was also examined. Data are described as median, 25-75th percentile, and range.
A binomial logistic regression model for discharge survival (main outcome) containing relevant predictors was created based on significant (p<0.05) and clinically relevant univariate factors. Predictor variables were categorized as follows: (1) age, (2) ISS, (3) presence of admission hypotension, (4) admission blood glucose (in milligrams per deciliter), (5) admission PaO 2 (group 1, PaO 2 ≤100 mmHg; group 2, PaO 2 101-300 mmHg; group 3, PaO 2 301-500 mmHg; and group 4, PaO 2 ≥500 mmHg) with group 1 as reference, and (6) admission PaCO 2 (group 1, PaCO 2 ≤35 mmHg; group 2, PaCO 2 036-45 mmHg; and group 3, PaCO 2 ≥46 mmHg) with group 1 as reference. Data are reported as adjusted odds ratio (AOR) and 95 % confidence interval (CI). p<0.05 was considered as statistically significant.
Results
Sample characteristics
Of the initial 201 patients whose data were available for analysis, 7 patients were excluded due to lack of laboratory data, leaving194 patients as the final sample. Of 194 patients, 162 (83.5 %) survived.
Cohort characteristics and baseline clinical differences between patients who survived compared with patients who died are described in Table 1 . Significant univariate associations for discharge survival were older age, higher admission GCS, lower ISS, higher admission PaO 2 , higher PaO 2 /FiO 2 , lower admission blood glucose, higher admission hematocrit, and absence of admission hypotension. There were no differences between those patients who survived and those who died at discharge in terms of presence or absence of chest injury, gender, or admission FiO 2 .
Admission PaO 2 thresholds and discharge survival Figure 1 shows the distribution of admission PaO 2 for survivors and for those who died at discharge. Children who survived had higher admission PaO 2 (344 vs. 125 mmHg, p<0.001) when compared with those who died ( Table 1) . Admission hypoxemia occurred in nine (5.6 %) patients who survived and eight (25 %) patients who died (p<0.001). Admission PaO 2 <100 mmHg was observed in fewer (20; 12.3 %) patients who survived than those who died (13; 40.6 %; p<0.001). Discharge survival was independently associated with PaO 2 301-500 mmHg (AOR, 8.02 (95 % CI, 1.73-37.10); p00.008; Table 2 ).
Admission PaCO 2 thresholds and discharge survival Figure 2 shows the distribution of PaCO 2 for survivors and those who died at discharge. There was no statistical difference in admission PaCO 2 between children who survived Table 2 ).
Other independent factors associated with discharge survival are older age (AOR01.13 (95 % CI01.02-1.26); p00.02) and lower ISS (AOR 0.94 (95 % CI00.91-0.97); p0<0.001; Table 2 ).
Discussion
The main findings of this study are that discharge survival in severe pediatric TBI was associated with (1) older age, (2) lower ISS, (3) admission PaO 2 301-500 mmHg, and (4) admission PaCO 2 036-45 mmHg. We also found that admission PaO 2 <100mHg and PaCO 2 <35 mmHg or PaCO 2 >45 mmHg were associated with higher discharge mortality. Together, these findings suggest optimal discharge outcomes for patients who have PaO 2 values greater than historical definitions of normoxemia (PaO 2 >100 mmHg) and with maintenance of normocarbia (PaCO 2 035-45 mmHg) early after severe pediatric TBI.
PaO 2 and survival in pediatric TBI
Current practice includes the use of 100 % oxygen during resuscitation [9] and empiric supplemental use of oxygen in pediatric patients after severe TBI is common, regardless of documented presence of hypoxemia. However, high fraction of inspired oxygen has been associated as oxygen toxicity to a number of organ systems [11] [12] [13] including the development of retinopathy of prematurity [14] , diffuse damage to the alveolar-capillary barrier leading to edema, impaired gas exchange, atelectasis, respiratory failure, and death [13, 15] . Specifically problematic for patients with TBI may be hyperoxic cerebral vasoconstriction [16] which may reduce CBF in the presence of normal cerebral metabolic rate, thereby worsening cerebral ischemia and poor outcomes [13, 17] .
The practice of maintaining high PaO 2 by supplemental oxygen appears to be based on data from adult TBI [18] or from experimental studies [19] and possibly due to concern for hypoxemia contributing to poor outcomes in pediatric TBI patients. While mitochondrial function may be impaired in patients with severe TBI, with subsequent decreased ATP production [20] , CMRO 2 has been shown to remain unchanged with hyperoxia in TBI patients indicating lack of advantage of the use of 100 % oxygen in patients with TBI to improve brain oxygen metabolism [11, 21] . Although we did not have cerebral metabolism data in this study, we found a survival benefit with admission PaO 2 301-500 mmHg after adjusting for other factors known to impact outcomes after TBI such as age and ISS. Our findings that PaO 2 <100 mmHg was associated with mortality is similar to a previously reported study in severe pediatric TBI [5] . However, older studies either examined the effect of hypoxemia alone (PaO 2 <60 mmHg) [6, 7] or failed to detect a PaO 2 threshold associated with survival/mortality [5] . In their study on children with severe pediatric TBI, Michaud et al. reported lower ED PaO 2 to be associated with increased discharge mortality and discharge disability. They found that patients with ED admission PaO 2 levels of ≥350 mmHg had lower discharge disability than those with PaO 2 levels between 105 and 350 mmHg [5] . In adult TBI, Davis et al. analyzed the relationship between admission hypoxemia and hyperoxemia on discharge survival and they, like the present study, reported peak discharge survival benefit to be associated with admission PaO 2 between 110 and 487 mmHg flanked by discharge mortality below PaO 2 110 mmHg and PaO 2 >487 mmHg. [22] . Together, these findings suggest a U-shaped effect of PaO 2 on discharge mortality in both adult and pediatric severe TBI. Skippen et al. studied the effect of hyperventilation on regional CBF in severe pediatric TBI [10] . They found a modest decrease in CBF but a much larger decrease in cerebral oxygen consumption. Absolute hyperemia was uncommon at any time, but measured CBF rates were still above the metabolic requirements of most children with TBI. They also demonstrated the increase in frequency of one or more regions of ischemia (CBF<18 mlmin −1 100 g −1
) from 28.9 % during normocapnia to 73.1 % with hyperventilation (PaCO 2 < 25 mmHg). Muizelaar et al., in their randomized control trial on hyperventilation in severe adult TBI, demonstrated deleterious effect of prophylactic hyperventilation in severe TBI with motor scores 4 to 5 [23] . Despite these two studies, there are insufficient data to conclusively establish the effect of early PaCO 2 on outcome in severe pediatric TBI. Michaud et al. [5] examined the effect of PaCO2<35 mmHg vs. PaCO 2 ≥35 mmHg on survival and found no association between these two groups. In another study, hypercarbia was defined as PaCO 2 >35 mmHg and was associated with poor survival. However, both studies grouped all levels of PaCO 2 greater than 35 mmHg into one category and there was no differentiation between normocarbia and hypercarbia. To overcome these study limitations, and to determine PaCO 2 threshold associated with survival/mortality, we defined hypocarbia as PaCO 2 ≤35 mmHg, normocarbia as PaCO 2 036-45 mmHg, and hypercarbia as PaCO 2 ≥46 mmHg.
In the present study, there was survival benefit with normocapnia (admission PaCO 2 036-45 mmHg) and increased mortality with both hypocapnia and hypercapnia (PaCO 2 beyond this range). These findings show the deleterious effects of both hypoventilation and hyperventilation in severe pediatric TBI and advocates for monitoring of ventilation with either PaCO 2 with capnogram or arterial blood gas early after severe TBI.
The main limitations of our study are the factors associated with a single-center retrospective study and the lack of brain tissue oxygenation and metabolic monitoring. As a result, we cannot comment if higher PaO 2 values resulted in higher cerebral oxygenation and increased survival in severe pediatric TBI. However, the use of these advanced neuromonitoring technique are currently not standard of care nor available at all clinical sites, leaving clinicians with questions as to how to use systemic oxygenation data to guide or modify TBI outcomes. While we cannot attribute the relationship of higher oxygen levels to brain tissue oxygenation thereby missing the mechanistic basis behind this observation, nevertheless, this preliminary would suggest that further examination of this association is warranted. Similarly we are unable to comment on the effects of PaCO 2 on hyperoxemia-induced cerebral vasoconstriction during hypocarbia or hypercarbia. Our study examined admission clinical and laboratory characteristics and survival/mortality in severe pediatric TBI but we are unable to comment on the duration of these admission clinical and laboratory characteristics which remained at or above/ below described levels. We were not able to examine interactions between PaO 2 and PaCO 2 given the number of patients in this study and only a few patients had admission hypotension in this series. Larger studies will be needed to fully understand the interrelationships between PaO 2 , PaCO 2 , and blood pressure on outcomes. Despite these limitations, we provide new information on admission oxygenation and ventilation parameters on patient level outcomes after severe TBI.
In summary, there are two new findings in this study. The first new finding is the association between discharge survival with admission PaO 2 301-500 mmHg and PaCO 2 036-45 mmHg in severe pediatric TBI. Second, both hypocarbia (PaCO 2 <35 mmHg) and hypercarbia (PaCO 2 >46 mmHg) were associated with increased discharge mortality. Together, these findings suggest the need for larger studies examining ways to optimize outcomes after pediatric TBI with PaO 2 and PaCO 2 .
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